<DOC>
	<DOCNO>NCT02860611</DOCNO>
	<brief_summary>Recent report show increase prevalence obesity patient type 1 diabetes ( T1DP ) study state patient type 2 diabetes ( T2DPs ) islet cell auto-antibodies . These result raise question common pathway T1DM T2DM via association T helper cell . In study investigator aim investigate difference T helper 1 ( Th1 ) cytokines level T1DPs , T2DPs healthy subject . The study include 114 T1DPs insulin treatment , 35 newly diagnose T2DPs use oral antidiabetic insulin 31 healthy subject ( CG ) . Serum interferon gamma ( IFN-γ ) , interleukin-2 ( IL-2 ) tumor necrosis factor alpha ( TNF-α ) level measure use ELISA method . Serum level cytokine T1DPs compare T2DPs control .</brief_summary>
	<brief_title>Comparison Th1 Cytokine Levels Between Type 1 Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Being &gt; 18 year old Giving consent participate Acute chronic inflammatory disease significant concomitant disease likely interfere glucose metabolism , malignancy , hemoglobinopathy , In addition , glucose intolerance ( fast glucose level glucose load ) HbA1C ≥ 5.7 % also use exclusion criterion control group , group American Diabetes Association ( ADA ) define prediabetes HbA1C 5.76.4 % ( Standards medical care diabetes 2012 . Diabetes care . 2012:35 . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Type 1 diabetes</keyword>
	<keyword>Type 2 diabetes</keyword>
	<keyword>T helper 1 cytokine</keyword>
</DOC>